| Hypoactive Sexual Desire Disorder |
1 |
0.89 |
| Testosterone |
0 |
0.82 |
| Testosterone Therapy |
0 |
0.71 |
| Hypogonadism |
0 |
0.59 |
| Clinical Guidelines |
0 |
0.35 |
| Breast Cancer |
0 |
0.32 |
| Sexual Dysfunction in Female |
0 |
0.24 |
| Sexual Health |
0 |
0.23 |
| Pain Management |
0 |
0.19 |
| Transdermal |
0 |
0.15 |
| Biologic Therapy |
0 |
0.14 |
| Sexual Dysfunction |
0 |
0.13 |
| Erectile Dysfunction |
0 |
0.12 |
| Diagnostic and Statistical Manual of Mental Disorders |
0 |
0.1 |
| Spinal Cord |
0 |
0.1 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.09 |
| Brain |
0 |
0.08 |
| Breast |
0 |
0.08 |
| Anxiety Disorder |
0 |
0.06 |
| Cancer Risk |
0 |
0.06 |
| Chronic Fatigue Syndrome |
0 |
0.06 |
| Depression |
0 |
0.06 |
| Infertility Male |
0 |
0.06 |
| Lipids Management |
0 |
0.06 |
| Menopause |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |
| Wound Management |
0 |
0.06 |
| Cancer |
0 |
0.05 |
| Child |
0 |
0.05 |
| Estrogen |
0 |
0.05 |
| Nerve |
0 |
0.05 |
| Physiology |
0 |
0.05 |
| Sexual Trauma |
0 |
0.05 |
| Steroids |
0 |
0.05 |
| Chronic Pelvic Pain |
0 |
0.04 |
| Functional MRI |
0 |
0.04 |
| Myalgia |
0 |
0.04 |
| Pelvic Pain |
0 |
0.04 |
| Sexual Abuse |
0 |
0.04 |
| Abuse |
0 |
0.03 |
| Adherence |
0 |
0.03 |
| Adverse Effects |
0 |
0.03 |
| Anxiety |
0 |
0.03 |
| Arteriovenous Malformation |
0 |
0.03 |
| Behavioral Problem |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Burns |
0 |
0.03 |
| Care Management |
0 |
0.03 |
| Cognition |
0 |
0.03 |
| Cognitive Behavioral Therapy |
0 |
0.03 |
| Dyspareunia |
0 |
0.03 |
| Epidemiology |
0 |
0.03 |
| Fatigue |
0 |
0.03 |
| Food and Drug Administration (FDA) |
0 |
0.03 |
| Hyperandrogenism |
0 |
0.03 |
| Hypoandrogenism |
0 |
0.03 |
| Injectable Medications |
0 |
0.03 |
| Investment |
0 |
0.03 |
| Liver |
0 |
0.03 |
| Magnetic Resonance Imaging |
0 |
0.03 |
| Meta-Analysis |
0 |
0.03 |
| Metabolism |
0 |
0.03 |
| Multidisciplinary Team |
0 |
0.03 |
| Neuropathy |
0 |
0.03 |
| Nonpharmacologic |
0 |
0.03 |
| Pain |
0 |
0.03 |
| Pelvis |
0 |
0.03 |
| Perineum |
0 |
0.03 |
| Postmenopause |
0 |
0.03 |
| Quality Control (QC) |
0 |
0.03 |
| Sexual Behavior |
0 |
0.03 |
| SNRI |
0 |
0.03 |
| Viagra |
0 |
0.03 |
| Vulvar Vestibulitis |
0 |
0.03 |
| Vulvodynia |
0 |
0.03 |